Monoamine oxidase A (MAO A) inhibitors decrease glioma progression

Glioblastoma (GBM) is an aggressive brain tumor which is currently treated with temozolomide (TMZ). Tumors usually become resistant to TMZ and recur; no effective therapy is then available. Monoamine Oxidase A (MAO A) oxidizes monoamine neurotransmitters resulting in reactive oxygen species which ca...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Kushal, Swati, Wang, Weijun, Vaikari, Vijaya Pooja, Kota, Rajesh, Chen, Kevin, Yeh, Tzu-Shao, Jhaveri, Niyati, Groshen, Susan L., Olenyuk, Bogdan Z., Chen, Thomas C., Hofman, Florence M., Shih, Jean C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924682/
https://ncbi.nlm.nih.gov/pubmed/26871599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7283
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller